The jury in Los Angeles superior court awarded $18m to Monica Kent and $22m to Deborah Schultz and her husband after finding that Johnson & Johnson knew for years its talc-based products were dangerous but failed to warn consumers. Erik Haas, Johnson & Johnson's worldwide vice-president of litigation, said in a statement the company plans to immediately appeal this verdict and expect to prevail as we typically do with aberrant adverse verdicts.
It is impossible to talk about cancer without invoking another Big C: cliche. Illness and pain, journeys and battles, finding appreciation for life while reckoning with death these are the building blocks of cancer stories, at once uniquely devastating and devastatingly common. The poets Andrea Gibson and Megan Falley, romantic partners for over a decade, took divergent approaches to the Big C. As a writer and editor, Falley strived to eradicate cliche; Gibson, as Falley put it, would instead double down.
Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and chemotherapy resistance in ovarian cancer cells, findings that may inform new targeted treatment approaches that inhibit this process and improve patient outcomes, according to a recent study published in The Journal of Clinical Investigation. Mazhar Adli, PhD, the Thomas J. Watkins Memorial Professor of Tumor Genomics, was senior author of the study.
I first ran the marathon in 2018 with a friend of mine, and I ran it again in 2023 with my brother, Larkin said. In 2024, I was diagnosed with ovarian cancer, and decided after I had this major operation and gone through chemo that I was gonna show up and run. In 2025, my cancer came back. Larkin's diagnosis has been an extensive challenge both physically and mentally.
The 67-year-old veteran journalist told her podcast listeners Thursday that the returning cancer was discovered in its earliest phase but had adhered a little bit to my pelvis. I have it again but it's being very well managed and so this is one of the whole things that people have to understand about some cancers, Amanpour said on Thursday's episode of the Changing the Ovarian Cancer Story podcast.
Since the 1970s, studies have indicated that talc may be carcinogenic even studies conducted by one of its biggest commercial producers, the US pharmaceutical company Johnson & Johnson. But many studies and experts suggest it's when talc is contaminated with asbestos that it becomes conclusively carcinogenic. Johnson & Johnson says its talc products "do not contain asbestos." However, after a series of court cases and multi-billion-dollar payouts, Johnson & Johnson stopped making talcum powder with talc in the early 2020s
Cytalux-administered via IV up to nine hours before surgery for ovarian cancer and up to 24 hours before surgery for lung cancer-works by attaching molecules of highly fluorescent, but harmless, dye to receptors that bring folate into cells. Because folate, a nutrient found in leafy greens and citrus fruits, supports cell growth and division-and cancer cells are always growing and dividing-folate receptors are often over-expressed in tumors.
In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of chemotherapy in animal experiments. Instead of attacking cancer directly, the first-of-its-kind strategy prevents cancer cells from evolving to withstand treatment - making the disease easier to target with existing drugs. Not only did the approach fully wipe out the disease to near completion in cellular cultures, but it also dramatically increased the effectiveness of chemotherapy in mouse models of human ovarian cancer.
"At 10:28 am on August 17th my gorgeous, hilarious, outspoken, warrior queen Mother - Gina Michelle DeBose - passed away due to complications with stage 3 ovarian cancer. I couldn't be more proud of her and how she fought this insidious disease over the past 3 years."